Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 38, 4585-4590, December 1, 1978]
© 1978 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Campbell, R. L.
Right arrow Articles by Nigro, N. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Campbell, R. L.
Right arrow Articles by Nigro, N. D.

Rat Liver Microsome-mediated N-Demethylation and Mutagenicity of Azoxymethane1

Robert L. Campbell2, John D. Suppnick, Joanne M. Hettrick and Norman D. Nigro3

Wayne State University School of Medicine, Department of Surgery, Detroit, Michigan 48201

The in vitro metabolism of azoxymethane (AOM), a highly specific intestinal carcinogen, was studied. Liver microsomes from male Sprague-Dawley rats in the presence of NADPH metabolize AOM to a mutagen detected by Ames' Salmonella typhimurium tester strains HisG46, TA1530, TA1535, and TA100 in liquid incubation. Mutagen formation was dependent on the length of incubation, microsomal protein, and AOM concentration, but its detection was most sensitive with strain TA100. The exact chemical nature of the mutagen was not determined.

An assay for the N-demethylation of AOM to formaldehyde by liver microsomes was also established. The reaction required reduced nicotinamide adenine dinucleotide phosphate and O2 thus exhibiting mixed-function oxidase characteristics. Pretreatment of animals with sodium phenobarbital or 3-methylcholanthrene did not significantly alter the specific activity of microsomal AOM N-demethylation but did increase microsomal cytochrome P-450 levels. Cobaltous chloride (60 mg/kg s.c.) reduced AOM N-demethylation, 49%; and cytochrome P-450, 69%. SKF-525A in vitro caused inhibition of AOM N-demethylation (43% initial activity at 3 mM), but 7,8-benzoflavone did not. Disulfiram, an inhibitor of 1,2-dimethylhydrazine and AOM carcinogenesis, reduced microsomal AOM N-demethylation by 70% when given at 0.25% (w/w) in Purina rat chow but did not alter cytochrome P-450 levels. The specific activity of microsomal AOM N-demethylation was significantly greater (+86%) when animals were fed a Purina rat chow diet than when fed a semisynthetic diet containing 56% dextrose, 25% casein, 7% salt mix, 5% corn oil, 5% bran, and 2% vitamin supplement. Compared to a semisynthetic diet control, AOM N-demethylationwas significantly increased by an 18-hr starvation period from the semisynthetic diet (+55%) or from the Purina rat chow diet (+ 175%). The addition of 30% beef fat, however, did not alter the specific activity of AOM N-demethylation.

1 Supported by the Matilda R. Wilson Fund.

2 Present address: The Procter and Gamble Co., Miami Valley Laboratories, P. O. Box 39175, Cincinnati, Ohio 45247.

3 To whom requests for reprints should be addressed.

Received 6/19/78. Accepted 9/19/78.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1978 by the American Association for Cancer Research.